Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peripheral neuropathy associated with simvastatin

T Phan1, J G McLeod, J D Pollard

  • 1Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Australia.

Journal of Neurology, Neurosurgery, and Psychiatry
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

Observation of tWZ Production at the CMS Experiment.

Physical review letters·2026
Same author

First Exclusive Reconstruction of the B^{*+}, B^{*0}, and B_{s}^{*0} Mesons and Precise Measurement of Their Masses.

Physical review letters·2026
Same author

Simultaneous Probe of the Charm and Bottom Quark Yukawa Couplings Using tt[over ¯]H Events.

Physical review letters·2026
Same journal

Diagnostic accuracy of a two-cut-off approach using the FAQ/MMSE ratio and FAQ for clinical preselection of patients for anti-amyloid therapy.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Cancer risk and mortality in patients with multiple sclerosis in Finland: a retrospective population-based cohort study.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Visuospatial working memory in Huntington's disease: behavioural and structural brain correlates.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Characteristics and outcomes in electric scooter-related traumatic brain injuries in Helsinki.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Durable fluoropolymer drug-eluting stent versus bare-metal stent for the prevention of intracranial in-stent restenosis.

Journal of neurology, neurosurgery, and psychiatry·2026
See all related articles

Simvastatin can cause sensorimotor neuropathy, a condition affecting nerves. Withdrawal of this cholesterol-lowering drug often leads to symptom improvement, highlighting its potential neurotoxicity.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Toxicology

Background:

  • Simvastatin is a widely prescribed statin medication used to lower cholesterol levels.
  • Peripheral neuropathy is a potential adverse effect of various medications, necessitating careful monitoring.

Observation:

  • Four patients developed sensorimotor neuropathy during simvastatin treatment, with symptom resolution upon drug withdrawal.
  • Onset of neuropathy varied, occurring within days to two years after starting simvastatin.
  • Electrophysiological and pathological findings indicated axonal degeneration consistent with toxic nerve damage.

Findings:

  • Simvastatin-induced neuropathy presents as axonal degeneration, affecting both motor and sensory nerves.
  • Evidence suggests potential toxic damage to anterior horn cells and dorsal root ganglia.

Related Experiment Videos

  • A significant number of reported cases show recovery after simvastatin cessation, with some experiencing recurrence upon re-exposure.

    • Implications:

    • Simvastatin should be considered a potential cause of peripheral neuropathy in clinical practice.
    • Early recognition and withdrawal of simvastatin are crucial for managing drug-induced neuropathy.
    • Further research into the mechanisms of statin-induced neurotoxicity is warranted.